Immunological age prediction in HIV-infected, ART-treated individuals

• Published in: Aging (Albany, NY.) NY.), 2021-10, Vol.13 (19), p.22772-22791
• Main Authors: de Armas, Lesley R, Pallikkuth, Suresh, Pan, Li, Rinaldi, Stefano, Pahwa, Rajendra, Pahwa, Savita
• Format: Article
• Language: English
• Subjects: Adult; Aged; Aging - immunology; Anti-HIV Agents - therapeutic use; Biomarkers - metabolism; Female; HIV Infections - drug therapy; Humans; Male; Middle Aged; Models, Biological; Research Paper; Young Adult
• ISSN: 1945-4589; 1945-4589
• DOI: 10.18632/aging.203625

Anti-retroviral therapy (ART) improves life expectancy in people living with HIV (PWH), but it remains unclear how chronic HIV infection affects normal aging of the immune system. Plasma cell-free protein expression and immune phenotypes were assessed in blood from ART treated PWH (19-77yrs, = 106) and age-matched, HIV-negative controls (HC, = 103). Using univariate spearman correlation, we identified 277 and 491 age-associated parameters out of a total 1,357 in HC and PWH, respectively. PWH exhibited shared and distinct age-associated immune profiles compared to HC highlighting the effect of HIV infection on immunological aging. Our analysis resulted in an 8-parameter, plasma-detectable inflammatory index that correlated with chronological age of all study participants but was higher overall in PWH. Additionally, predictive modeling for age in HC participants and age-associated parameters generated a 25-parameter signature, IMAP-25, with 70% and 53% accuracy in HC and PWH, respectively. Applying the IMAP-25 signature to immunological data from PWH revealed accelerated aging in PWH by 5.6 yrs. Overall, our results demonstrate that immune signatures, easily monitored in human blood samples, can be used as an indicator of one's 'immunological age' during ART-treated HIV infection and can be applied to other disease states that affect the immune system.